Senores Pharmaceuticals Limited — Important, 26-08-2026: Updates
26-08-2026 | 06:50 pm
26-08-2026 | 06:50 pm
Senores Pharma's board approved an ESOS 2026 of 0.0472 Cr options for employees (subject to shareholder approval). The company also decided to incorporate wholly-owned subsidiaries in Mexico and Canada to expand its international market presence.
No comments yet. Be the first to comment!
